Basic Info
  • Grade: Pharmaceutical Grade

    Factory Location: Chengdu, Sichuan, China

    Main Sales Markets: Central/South America,Eastern Europe,Asia,Middle East,Africa

  • Sample Provided: yes

    Payment Terms: L/C

    Name:

    Human Immunoglobulin (pH4) for Intravenous Injection (IVIG)

    Use within:

    36 months

    Specifications:

    1.25g/vial (5%, 25ml)

    2.5g/vial (5%, 50ml)

    5g/vial (5%, 100ml)

    Approval Numbers:

    1.25g/vial (5%, 25ml) - NMPA Approval No. S10980025

    2.5g/vial (5%, 50ml) - NMPA Approval No. S10980026

    5g/vial (5%, 100ml) - NMPA Approval No. S20013037

    Indications:

    1.Primary Immunodeficiency Diseases (PID) such as X-linked hypoimmunoglobulinemia, common variant immunodeficiency disease, and immunoglobulin G subtype deficiency disease.

    2.Secondary Immunodeficiency Diseases such as severe infections and neonatal sepsis.

    3.Autoimmune diseases such as idiopathic thrombocytopenic purpura and Kawasaki disease.

Send your message to this supplier
  • From:
  • To:
    Grand Shuyang Life Sciences (Chengdu) Co.,Ltd.
  • Send a Copy to this Email
  • Message:
    Upload Images / Files
    - Supports jpg, jpeg, png,
     gif, pdf, doc, docx,
     xls, xlsx, txt, rar and zip
    - Max upload 3 files;
     Max  total size: 3MB
    (0/3)

    Enter between 20 to 4,000 characters.This is not what you are looking for ? Post a Sourcing Request Now

  • Verification:
PharmaSources Customer Service